DrugPatentWatch Database Preview
PERJETA Drug Profile
Summary for Tradename: PERJETA
| Patents: | 139 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PERJETA |
Pharmacology for PERJETA
| Mechanism of Action | HER2/Neu/cerbB2 Antagonists |
US Patents for PERJETA
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | LegoChem Biosciences, Inc. (Daejeon, KR) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | Genentech, Inc. (South San Francisco, CA) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | Plexxikon Inc. (Berkeley, CA) | ➤ Sign Up | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | ➤ Sign Up | RX | search | ||
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | ➤ Sign Up | Ablynx N.V. (Ghent-Zwijnaarde, BE) | ➤ Sign Up | RX | search | |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for PERJETA
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011066378 | ➤ Sign Up |
| Canada | 2706675 | ➤ Sign Up |
| Israel | 196028 | ➤ Sign Up |
| Cyprus | 1118199 | ➤ Sign Up |
| Taiwan | 200640488 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for PERJETA
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2015000013 | Germany | ➤ Sign Up | PRODUCT NAME: POMALIDOMID UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE, HYDRATE ODER STEREOISOMERE (IMNOVID); REGISTRATION NO/DATE: EU/1/13/850 20130805 |
| 140 | Estonia | ➤ Sign Up | |
| 642 | Luxembourg | ➤ Sign Up | PRODUCT NAME: POMALIDOMIDE ET SES SELS, SOLVATES, HYDRATES OU STEREOISOMERES PHARMACEUTIQUEMENT ACCEPTABLES QUI EN DERIVENT (IMNOVID); FIRST REGISTRATION DATE: 20130805 |
| 2015 00006 | Denmark | ➤ Sign Up | PRODUCT NAME: POMALIDOMID OG FARMACEUTISK ACCEPTABLE SALTE, SOLVATER, HYDRATER ELLER STEREOISOMERER HERAF; REG. NO/DATE: EU/1/13/850 20130805 |
| 90004-6 | Sweden | ➤ Sign Up | PRODUCT NAME: POMALIDOMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS, SOLVATES, HYDRATES OR STEREOISOMERS THEREOF; REG. NO/DATE: EU/1/13/850 20130808 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
